Persistent URL of this record https://hdl.handle.net/1887/96264
In Collections
This item can be found in the following collections:
![Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prosp](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
- All authors
- Schoffski, P.; Sufliarsky, J.; Gelderblom, H.; Blay, J.Y.; Strauss, S.J.; Stacchiotti, S.; Rutkowski, P.; Lindner, L.H.; Leahy, M.G.; Italiano, A.; Isambert, N.; Debiec-Rychter, M.; Sciot, R.; Cann, T. van; Marreaud, S.; Nzokirantevye, A.; Collette, S.; Wozniak, A.
- Date
- 2018-06-30
- Journal
- Lancet Respiratory Medicine
- Volume
- 6
- Issue
- 6
- Pages
- 431 - 441